Khadela A, Parikh R, Vaghela J, Chauhan Y, et al. A Real-World Phase IV Superiority Trial and Cost-Effectiveness Analysis of the Addition of Low-Dose Nivolumab to Triple Metronomic Chemotherapy Compared to the Paclitaxel Carboplatin Regimen in Recurrent or Metastatic Head and Neck Cancer Patients. Head Neck 2025 Oct 17. doi: 10.1002/hed.70077.
PMID: 41104574